HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California Cosmetics Bill Implementation Likely To Occur In Stages – CTFA

This article was originally published in The Rose Sheet

Executive Summary

The California Department of Health Services likely will implement the California Safe Cosmetics Act in stages, and could decide to extend the Jan. 1 effective date altogether, according to CTFA Exec VP-Government Affairs John Hurson

You may also be interested in...



Industry Looks For New Year Resolution Of Issues With Calif. Cosmetics Law

The Personal Care Products Council is optimistic that issues hindering industry's compliance with the California Safe Cosmetics Act (SB 484) will be resolved early next year

Industry Looks For New Year Resolution Of Issues With Calif. Cosmetics Law

The Personal Care Products Council is optimistic that issues hindering industry's compliance with the California Safe Cosmetics Act (SB 484) will be resolved early next year

Lead-In-Lipstick Row Creates Opportunity For Some, Puts Others On Defensive

Lipstick marketers Markwins and Eco Lips respond in Oct. 23 press releases to a recent study identifying lead in lipsticks - the former reasserting the safety of its products and the latter using the occasion to highlight the absence of lead in its offerings

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014068

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel